ReviewPharmaceutics2022
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy.
Lingling Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it
ReviewPharmaceutics2022
Lingling Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.